Terms: = Liver cancer AND SYK, P43405, 6850, ENSG00000165025 AND Treatment
11 results:
1. American Joint Committee on cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma.
Jia S; Zhu T; Shi H; Zong C; Bao Y; Wen X; Ge S; Ruan J; Xu S; Jia R; Fan X
Ophthalmology; 2022 Jul; 129(7):771-780. PubMed ID: 35245602
[TBL] [Abstract] [Full Text] [Related]
2. Kinase Inhibition as treatment for Acute and Chronic Graft-
Braun LM; Zeiser R
Front Immunol; 2021; 12():760199. PubMed ID: 34868001
[TBL] [Abstract] [Full Text] [Related]
3. Dual inhibition of reactive oxygen species and spleen tyrosine kinase as a therapeutic strategy in liver fibrosis.
Hu Q; Liu M; You Y; Zhou G; Chen Y; Yuan H; Xie L; Han S; Zhu K
Free Radic Biol Med; 2021 Nov; 175():193-205. PubMed ID: 34492311
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive Analysis of Competing Endogenous RNA Network Focusing on Long Noncoding RNA Involved in Cirrhotic Hepatocellular Carcinoma.
Zhang Y; Chen D; Yang M; Qian X; Long C; Zheng Z
Anal Cell Pathol (Amst); 2021; 2021():5510111. PubMed ID: 34258170
[TBL] [Abstract] [Full Text] [Related]
5. Recent Improvements in Racial Disparity in the treatment of Hepatocellular Carcinoma: How Times Have Changed.
Moten AS; Fagenson AM; Pitt HA; Lau KN
J Gastrointest Surg; 2021 Oct; 25(10):2535-2544. PubMed ID: 33547582
[TBL] [Abstract] [Full Text] [Related]
6. A new clinical prognostic nomogram for liver cancer based on immune score.
Shen Q; Hu G; Wu J; Lv L
PLoS One; 2020; 15(7):e0236622. PubMed ID: 32730361
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of the deubiquitinase USP10 induces degradation of syk.
Yang J; Meng C; Weisberg E; Case A; Lamberto I; Magin RS; Adamia S; Wang J; Gray N; Liu S; Stone R; Sattler M; Buhrlage S; Griffin JD
Br J Cancer; 2020 Apr; 122(8):1175-1184. PubMed ID: 32015510
[TBL] [Abstract] [Full Text] [Related]
8. Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.
Perova T; Grandal I; Nutter LM; Papp E; Matei IR; Beyene J; Kowalski PE; Hitzler JK; Minden MD; Guidos CJ; Danska JS
Sci Transl Med; 2014 May; 6(236):236ra62. PubMed ID: 24828076
[TBL] [Abstract] [Full Text] [Related]
9. Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.
Travert M; Huang Y; de Leval L; Martin-Garcia N; Delfau-Larue MH; Berger F; Bosq J; Brière J; Soulier J; Macintyre E; Marafioti T; de Reyniès A; Gaulard P
Blood; 2012 Jun; 119(24):5795-806. PubMed ID: 22510872
[TBL] [Abstract] [Full Text] [Related]
10. PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
Shen B; Chu ES; Zhao G; Man K; Wu CW; Cheng JT; Li G; Nie Y; Lo CM; Teoh N; Farrell GC; Sung JJ; Yu J
Br J Cancer; 2012 Apr; 106(9):1486-94. PubMed ID: 22472882
[TBL] [Abstract] [Full Text] [Related]
11. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
[TBL] [Abstract] [Full Text] [Related]
